163 related articles for article (PubMed ID: 37381011)
1. ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation.
Man D; Jiang Y; Zhang D; Wu J; Ding B; Liu H; Xu G; Lu J; Ru J; Tong R; Zheng S; Chen D; Wu J
J Transl Med; 2023 Jun; 21(1):420. PubMed ID: 37381011
[TBL] [Abstract][Full Text] [Related]
2. Identification and Experimental Validation of the Prognostic Significance and Immunological Correlation of Glycosylation-Related Signature and ST6GALNAC4 in Hepatocellular Carcinoma.
Dai T; Li J; Liang RB; Yu H; Lu X; Wang G
J Hepatocell Carcinoma; 2023; 10():531-551. PubMed ID: 37034303
[TBL] [Abstract][Full Text] [Related]
3. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J
J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
[TBL] [Abstract][Full Text] [Related]
4. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis.
Mamiya T; Yamazaki K; Masugi Y; Mori T; Effendi K; Du W; Hibi T; Tanabe M; Ueda M; Takayama T; Sakamoto M
Lab Invest; 2010 Sep; 90(9):1339-45. PubMed ID: 20531292
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of ST6Gal-I expression in human hepatocellular carcinoma cells inhibits their exosome-mediated proliferation- and migration-promoting effects.
Wang L; Chen X; Wang L; Wang S; Li W; Liu Y; Zhang J
IUBMB Life; 2021 Nov; 73(11):1378-1391. PubMed ID: 34559939
[TBL] [Abstract][Full Text] [Related]
6. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
Gao W; Chen X; Chi W; Xue M
Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 upregulates Fut8 expression by activating the Wnt/β-catenin pathway to enhance HCC cell proliferative and invasive ability.
Zhang C; Wu Q; Huang H; Chen X; Huang T; Li W; Zhang J; Liu Y
Cell Biol Int; 2020 Nov; 44(11):2202-2212. PubMed ID: 32710651
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor.
Abu El-Makarem MA; Kamel MF; Mohamed AA; Ali HA; Mohamed MR; Mohamed AEM; El-Said AM; Ameen MG; Hassnine AA; Hassan HA
PLoS One; 2022; 17(11):e0277266. PubMed ID: 36374927
[TBL] [Abstract][Full Text] [Related]
9. HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-β axis.
Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L
Biochem Biophys Res Commun; 2018 Nov; 506(1):189-193. PubMed ID: 30342849
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.
Peng R; Zhang PF; Yang X; Wei CY; Huang XY; Cai JB; Lu JC; Gao C; Sun HX; Gao Q; Bai DS; Shi GM; Ke AW; Fan J
J Exp Clin Cancer Res; 2019 Mar; 38(1):113. PubMed ID: 30836988
[TBL] [Abstract][Full Text] [Related]
12. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
14. Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness.
Ning J; Ye Y; Bu D; Zhao G; Song T; Liu P; Yu W; Wang H; Li H; Ren X; Ying G; Zhao Y; Yu J
Mol Ther; 2021 Jun; 29(6):2067-2087. PubMed ID: 33601054
[TBL] [Abstract][Full Text] [Related]
15. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
16. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma.
Dong P; Wang X; Liu L; Tang W; Ma L; Zeng W; Sun S; Zhang L; Zhang N; Shen X; Janssen HLA; Dong L; Zhang S; Chen S
J Hepatol; 2020 Dec; 73(6):1446-1459. PubMed ID: 32610114
[TBL] [Abstract][Full Text] [Related]
17. YAP-1 Promotes Tregs Differentiation in Hepatocellular Carcinoma by Enhancing TGFBR2 Transcription.
Fan Y; Gao Y; Rao J; Wang K; Zhang F; Zhang C
Cell Physiol Biochem; 2017; 41(3):1189-1198. PubMed ID: 28472799
[TBL] [Abstract][Full Text] [Related]
18. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
Hou H; Ge C; Sun H; Li H; Li J; Tian H
Cancer Sci; 2018 Apr; 109(4):1088-1100. PubMed ID: 29377347
[TBL] [Abstract][Full Text] [Related]
19. Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significance.
Sakabe T; Tsuchiya H; Kanki K; Azumi J; Gonda K; Mizuta Y; Yamada D; Wada H; Shomori K; Nagano H; Shiota G
PLoS One; 2013; 8(2):e56197. PubMed ID: 23457527
[TBL] [Abstract][Full Text] [Related]
20. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
Zhang Q; Cheng S; Cao L; Yang J; Wang Y; Chen Y
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32077915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]